Since the company registration one hundred and nineteen events have happened. The last three records are Confirmation statement made on 1 March 2017 with updates; Total exemption full accounts made up to 31 December 2015; Annual return made up to 1 March 2016 with full list of shareholders Statement of capital on 2016-04-11 GBP 3,333,907.1 . The most likely internet sites of GENOSIS LIMITED are www.genosis.co.uk, and www.genosis.co.uk. The predicted number of employees is 1 to 10. The company’s age is twenty years and nine months. The distance to to Byfleet & New Haw Rail Station is 5 miles; to Feltham Rail Station is 6.1 miles; to Brentford Rail Station is 8.9 miles; to Barnes Bridge Rail Station is 8.9 miles is 2.7 miles. This is straight distance. Please bear in mind the walking distance could be longer.Genosis Limited is a Private Limited Company. The company registration number is 05379251. Genosis Limited has been working since 01 March 2005. The present status of the company is Active. The registered address of Genosis Limited is 30 Clare Hill Esher Surrey Kt10 9nb. The company`s financial liabilities are £5k. It is £0.56k against last year. And the total assets are £10.56k, which is £10.56k against last year. POCKSON, Jonathan Richard Hayward Hastings is a Secretary of the company. BATEMAN, Paul North is a Director of the company. Secretary ARCHER, David Birdwood has been resigned. Secretary STEWARD, Mandy Jayne has been resigned. Nominee Secretary SWIFT INCORPORATIONS LIMITED has been resigned. Director BLAKER, Graham Joseph, Dr has been resigned. Director FORREST, Gordon Coulter, Dr has been resigned. Director POCKSON, Jonathan Richard Hayward Hastings has been resigned. Director RATTLE, Simon John, Dr has been resigned. Director SIMON, Ann Juliet Bateman, Dr has been resigned. Director THOMPSON, Robert Ferguson has been resigned. Nominee Director INSTANT COMPANIES LIMITED has been resigned. Nominee Director SWIFT INCORPORATIONS LIMITED has been resigned. The company operates in "Research and experimental development on biotechnology".